Drug distributor pays record fine January 24, 2017 By Christine Blank McKesson Corp., one of the largest distributors of pharmaceuticals, agreed to pay a record civil penalty for alleged violations of the Controlled Substances Act. Constipation drug wins approval January 23, 2017 By Christine Blank FDA approved plecanatide (Trulance, Synergy Pharmaceuticals) for adults with chronic idiopathic constipation. Trump's drug pricing comments create debate January 17, 2017 By Christine Blank While President-elect Donald Trump recently said that the pharmaceutical industry is “getting away with murder” in terms of drug prices, the industry is trying to self-regulate before facing tighter rules from the incoming administration. New 340B drug rule sets drugmaker fines January 09, 2017 By Christine Blank Consumer health groups are praising Health and Human Services’ (HHS) new rule on the Medicaid 340B drug discount program, which sets a ceiling on drug prices. Why 2016 drug approvals fell January 02, 2017 By Christine Blank While FDA approved far fewer new drugs in 2016 than 2015, the agency quickly approved novel and breakthrough therapies. New device could be breakthrough for diabetics January 02, 2017 By Christine Blank FDA recently expanded approval of the G5 Mobile Continuous Glucose Monitoring System (Dexcom) to allow for replacement of fingerstick blood glucose (sugar) testing for diabetics. New diabetes combo drug available soon December 19, 2016 By Christine Blank A new combination drug for type 2 diabetes will available in the US in the coming months. FDA issues warnings over anesthesia, diabetes drugs December 16, 2016 By Christine Blank FDA issued two important drug warnings this week: one linking certain diabetes medications to bladder cancer and another about the use of general anesthetic and sedation drugs during pregnancy. FDA approves expansion of Avastin in ovarian cancer December 08, 2016 By Christine Blank FDA recently approved bevacizumab (Avastin, Genentech) for patients with platinum-sensitive recurrent epithelial ovarian (psOC), fallopian tube or primary peritoneal cancer. US drug spending predicted to drop December 07, 2016 By Christine Blank The US growth rate for spending on medicines is expected to fall in 2016 and beyond, according to new research.